Muhammad Irfan | Cell Structure Analysis | Best Researcher Award

Dr. Muhammad Irfan | Cell Structure Analysis | Best Researcher Award

Dr. Muhammad Irfan , University of sargodha , Pakistan

Dr. Muhammad Irfan, born on April 1, 1983, in Sargodha, is an expert in condensed matter physics with a focus on electronic structure calculations using Density Functional Theory (DFT). He holds a Ph.D. in Physics from the University of Sargodha (2019) and has contributed significantly to the study of electronic, optical, and thermoelectric properties of solid materials. His research is instrumental in optimizing semiconductors used in energy-efficient devices like photovoltaic cells, LEDs, and thermoelectric materials. Dr. Irfan has a wide array of publications in high-impact journals, demonstrating his expertise in material science. With extensive teaching experience and active involvement in research, Dr. Irfan has established himself as a key figure in his field.

Publication Profile:

Scopus

Strengths for the Award:

Dr. Muhammad Irfan has made significant contributions to the field of condensed matter physics, particularly through his work on Density Functional Theory (DFT) simulations. His research has a broad scope, covering material properties such as electronic structure, elasticity, magnetism, and thermoelectrics. His work on optimizing semiconductors for energy-efficient devices like photovoltaics, LEDs, and thermoelectric materials showcases his strong focus on practical applications, contributing to advancements in renewable energy and energy conversion technologies. Dr. Irfan’s extensive publication record in high-impact journals demonstrates his high level of expertise and research capability. His interdisciplinary approach and ability to conduct in-depth simulations make him a strong candidate for the award.

Areas for Improvements:

While Dr. Irfan has an excellent academic background and research experience, expanding his collaborations with international research groups and engaging more in cross-disciplinary research could further enhance the global impact of his work. Additionally, focusing on the development of new experimental techniques or contributing more to patentable technologies would strengthen his standing in the broader scientific community.

Education:

Dr. Irfan’s academic journey began at the University of Sargodha, where he completed his M.Sc. (2006) and M.Phil. (2013) in Physics with top grades. He later earned his Ph.D. in 2019 from the same institution. In addition to his studies in Physics, Dr. Irfan also pursued an M.Ed. (2014) and B.Ed. (2011) from the Allama Iqbal Open University, Islamabad. His commitment to learning is reflected in his strong academic record, with distinctions in all his degrees, and he consistently strives to enhance his knowledge in both teaching and research.

Experience:

Dr. Irfan has diverse teaching experience, serving as an Assistant Professor (visiting) at the University of Lahore and a Research Assistant at Riphah International University. Over the years, he has contributed to various graduate and undergraduate programs, where he specialized in Physics and material science. His teaching approach is grounded in both theoretical and practical applications of condensed matter physics, ensuring that students develop a solid understanding of the subject. Dr. Irfan’s research-driven approach also enhances his teaching, bridging the gap between academia and real-world applications.

Research Focus:

Dr. Irfan’s research primarily focuses on the electronic structure, elasticity, thermoelectric properties, and magnetism of materials using Density Functional Theory (DFT). His work is pivotal in optimizing the properties of semiconductors for advanced applications in energy conversion, photovoltaics, and optoelectronics. He explores the interaction between materials and their interfaces, ensuring efficient charge and heat transfer. By investigating thermoelectric materials with high electrical conductivity and low thermal conductivity, Dr. Irfan aims to improve energy efficiency and sustainability, especially in waste heat recovery and energy conversion technologies.

Publications Top Notes:

  1. Optoelectronic structure and related transport properties of Ag2Sb2O6 and Cd2Sb2O7. 📚
  2. Fermi Surface and Optoelectronic Properties of Pyrochlore Oxide Superconductor (Kos2o6). 📖
  3. Enhanced thermoelectric properties of ASbO3 due to decreased band gap. 🔬
  4. Effects of compressed strain on thermoelectric properties of Cu3SbSe4. ⚡
  5. Structural, electronic, optical, and elastic properties of Ca2Nb2O7 crystals. 🔍
  6. Effect of Coulomb interactions on optoelectronic and magnetic properties of A2V2O7 compounds. 🧪
  7. Thermoelectric features of CaPd3B4O12 perovskites following DFT calculations. 🌍
  8. Doping-induced effects on optical and band structure properties of Sr2Si5N8 phosphors. 💡
  9. Optoelectronic properties of CaO: Eu+2 for energy applications. 🔋
  10. Elastic and optoelectronic properties of CaTa2O6 compounds. 🌟
  11. Doping effects on optical properties of Sr2Si5N8 phosphors: DFT approach. 📊

Conclusion:

Dr. Muhammad Irfan’s exceptional expertise in condensed matter physics, coupled with his consistent academic achievements and dedication to practical applications in renewable energy and materials science, makes him a strong contender for the Research for Best Researcher Award. His contributions have already provided valuable insights into material science, and with ongoing collaborations and innovations, he has the potential to make even greater strides in advancing sustainable technology.

 

 

 

Mini Dahiya | Neuropharmacology | Young Scientist Award

Mrs. Mini Dahiya | Neuropharmacology | Young Scientist Award

Mrs. Mini Dahiya , UIPS, Panjab University , India

Mini Dahiya is a Ph.D. Research Scholar at the University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, specializing in neuropharmacology. With over five years of research experience, she has contributed significantly to the field through more than 20 publications in prominent journals. Dahiya’s academic excellence is evident as she secured the first rank in the Panjab University Ph.D. entrance test and was a Gold Medalist in her Master’s in Pharmacy program. She has received international recognition, being honored with travel fellowships by the Alzheimer’s Association International Conference. Dahiya is a member of ISTAART (International Society to Advance Alzheimer’s Research and Treatment) and is a registered pharmacist with the Haryana State Pharmacy Council. Her work focuses on the molecular mechanisms involved in neurological diseases, particularly Alzheimer’s, aiming to discover new therapeutic avenues.

Publication Profile:

Scopus

Strengths for the Award:

Mini Dahiya demonstrates exceptional potential as a young scientist in the field of neuropharmacology. Her academic journey is marked by significant accomplishments, such as securing the 1st rank in the Panjab University Ph.D. entrance exam and earning a Gold Medal in her Master’s program. Her research focus on neurodegenerative diseases, particularly Alzheimer’s, and her exploration of drug interactions with specific neurological pathways is impactful. With over 20 publications in respected journals and books, Dahiya’s work has gained attention in the scientific community, underscoring her dedication and depth of knowledge. The travel fellowships she received from the Alzheimer’s Association further emphasize her recognition on the global stage. Her citation index of 11 and membership in prestigious organizations like ISTAART solidify her position as a promising researcher.

Areas for Improvement:

While Mini Dahiya’s research contributions are commendable, there is room for expanding her collaborations and industry connections to enhance her research outcomes and impact. Future industry partnerships or consultancy projects would be valuable, especially in applying her research on neuropharmacology in clinical settings. Additionally, enhancing interdisciplinary collaborations might lead to a more holistic understanding of neurological disorders and broaden her scope of impact.

Education:

Mini Dahiya completed her Bachelor’s in Pharmacy from the University Institute of Pharmaceutical Sciences, Panjab University, where she displayed a strong academic foundation. She further pursued her Master’s in Pharmacy, securing a Gold Medal for her academic excellence. Dahiya’s rigorous academic journey continued with her enrollment in the Ph.D. program at Panjab University, where she focused on neuropharmacology. Her research has provided innovative insights into drug interactions, mechanisms of action, and neurodegenerative diseases. Her achievements reflect her commitment to excellence in the field, marked by consistent recognition, such as securing the first rank in the university’s Ph.D. entrance examination. The combination of her deep academic knowledge and practical research experience has positioned Dahiya as a promising researcher in the pharmaceutical sciences.

Experience:

Mini Dahiya brings over five years of research experience in the field of neuropharmacology, during which she has demonstrated a strong focus on understanding neurological disorders. She has worked on various research projects aimed at exploring drug mechanisms in diseases such as Alzheimer’s and other neurodegenerative conditions. Dahiya has an impressive portfolio of more than 20 publications, including book chapters and peer-reviewed articles in high-impact journals. As a recognized scholar in her field, Dahiya has also been awarded travel fellowships to attend international conferences, including the Alzheimer’s Association International Conference. Her research contributions are a testament to her dedication and passion for advancing the knowledge in neuropharmacology. Dahiya’s professional journey is complemented by her role as a registered pharmacist with the Haryana State Pharmacy Council, and she actively contributes to global research communities such as ISTAART.

Research Focus:

Mini Dahiya’s research primarily focuses on neuropharmacology, specifically investigating the molecular mechanisms behind neurodegenerative diseases like Alzheimer’s. Her work centers on the development of innovative therapies that target specific receptors or pathways involved in these disorders. By understanding the interaction between various drugs and biological targets, Dahiya aims to create more effective treatments that address the root causes of neurological diseases. Her ongoing work includes analyzing drug repurposing strategies to explore existing treatments for new therapeutic uses, particularly in Alzheimer’s and cancer. Dahiya is also keen on understanding chemotherapy-induced cognitive decline and its impact on brain function. Through her research, she hopes to bridge the knowledge gap in neuropharmacology, contributing significantly to the discovery of new drug candidates that can alleviate or slow the progression of neurodegenerative diseases.

Publication Top Notes:

  1. Therapeutic Targeting of Antineoplastic Drugs in Alzheimer’s Disease: Discovered in Repurposed Agents 📚
  2. Drug Repurposing: An Advance Way to Traditional Drug Discovery 🔄
  3. Therapeutic Repurposing Approach: New Opportunity for Developing Drugs Against COVID-19 💊
  4. Prognosticating Drug Targets and Responses by Analyzing Metastasis-Related Cancer Pathways 🧬
  5. Emerging Pathophysiology and Treatment of Prostate Cancer: Future Perspective 🦠
  6. Current Pathophysiology, Treatment, and Future Perspective for Prostate Cancer 🎗
  7. Potential Pathways for Chemotherapy-Induced Cognitive Decline 🧠
  8. Eliminating the Knowledge Gap of Overlapped Mechanisms of Diabetes and Neurological Disorders 💉
  9. Phytochemical Analysis and In vitro Evidence of Antimalarial, Antibacterial, Antifungal, Antioxidant and Anti-Inflammatory Activities of Emblica Officinalis Fruit 🌱

Conclusion:

Mini Dahiya is a highly deserving candidate for the Young Scientist Award due to her substantial research achievements, strong academic background, and continued commitment to advancing neuropharmacology. She has made significant contributions to understanding drug interactions in neurological diseases, particularly Alzheimer’s, and is poised to further her career as an influential scientist. The award would provide an excellent platform to recognize and support her future endeavors, encouraging her to expand her research impact globally.

 

 

 

Arunima Biswas | Cancer Cell Biology | Best Researcher Award

Assist. Prof. Dr. Arunima Biswas | Cancer Cell Biology | Best Researcher Award

Assist. Prof. Dr. Arunima Biswas , university of kalyani , India

Dr. Arunima Biswas is an Assistant Professor in the Department of Zoology at the University of Kalyani, India. With a Ph.D. in Biochemistry from the Indian Institute of Chemical Biology, Kolkata, she has focused her career on understanding the molecular mechanisms underlying diseases, particularly cancer and parasitic infections. She leads multiple funded research projects, aiming to develop targeted therapies for various cancers. Dr. Biswas has worked extensively on the cyclic nucleotide signaling pathways in unicellular eukaryotes like Leishmania and cancer. A passionate educator and researcher, she mentors Ph.D. students and collaborates with international scientists to advance medical research.

Publication Profile:

Scopus

Strengths for the Award:

Dr. Arunima Biswas demonstrates significant contributions to cancer research and parasitology. She is highly skilled in understanding and manipulating cyclic nucleotide signaling pathways, which play a crucial role in cancer biology and parasitic diseases like Leishmania infections. With several ongoing research projects, including the repurposing of phosphodiesterase inhibitors for cancer therapy and the development of targeted drug delivery systems, Dr. Biswas has shown an innovative approach to solving complex medical challenges. Her leadership as Principal Investigator for high-impact projects, such as cancer screening and drug targeting, highlights her as a leading researcher in her field. Furthermore, her dedication to mentoring and producing highly qualified Ph.D. students is commendable.

Areas for Improvement:

While Dr. Biswas’ research is already impactful, expanding her work on the practical clinical application of her findings could further bridge the gap between research and patient care. Collaboration with clinical trials or hospitals could expedite the translation of her findings into therapeutic solutions. Additionally, expanding interdisciplinary collaborations could bring novel insights into her research.

Education:

Dr. Arunima Biswas earned her Ph.D. in Biochemistry from the Indian Institute of Chemical Biology, Kolkata, with a thesis on Host-parasite interaction: Modulation of signaling pathways in Macrophage and Leishmania (2010). Prior to this, she completed her Master of Science in Zoology from the University of Calcutta with First Class honors (2005). She also holds a Bachelor of Science in Zoology from Maulana Azad College, University of Calcutta (2003). Her academic journey has been marked by a strong foundation in biochemistry, signaling pathways, and parasitology, forming the basis of her current research interests.

Experience:

Dr. Arunima Biswas has over a decade of teaching and research experience. As an Assistant Professor at the University of Kalyani, she has significantly contributed to the academic and research growth in the Department of Zoology. She is the Principal Investigator of several research projects funded by national bodies like CSIR, SERB, and UGC, with an emphasis on cancer research, especially targeting pathways involving cyclic nucleotides. Dr. Biswas has also collaborated with multiple national and international institutions and mentored several Ph.D. students, contributing to their academic and research advancements. Her experience in guiding research and mentoring future scientists is widely acknowledged.

Awards and Honors:

Dr. Arunima Biswas has received numerous accolades for her research and academic contributions. Notably, she won the Young Scientist Presentation Award at the Translational Cancer Research Conference (2020) and was honored with an International Congress of Cell Biology Travel Award (2016). She also received the American Society of Biochemistry and Cell Biology Travel Award (2015) and the prestigious DST-INSPIRE Faculty Scheme award (2012). These recognitions underscore her outstanding contributions to biomedical research, particularly in cancer biology and parasitology, further establishing her as a leader in her field.

Research Focus:

Dr. Arunima Biswas’s research focuses on cancer biology and parasitology, particularly the role of cyclic nucleotide signaling in cancer and Leishmania infections. She investigates therapeutic targets to modulate these pathways for better treatment options in cancer, including breast and gynecological cancers. Her ongoing projects include exploring phosphodiesterase inhibitors for breast cancer and cervical cancer, as well as developing vesicular drug carriers for targeted drug delivery. Dr. Biswas is dedicated to understanding the molecular intricacies of host-parasite interactions and their implications for disease management.

Publications Top Notes:

  1. Metal Oxide–Enhanced Para-Coumaric Acid Nanoparticles for Precision Targeting of Leishmania donovani
  2. Repurposing Approved Protein Kinase Inhibitors as Potent Anti-Leishmanials Targeting Leishmania MAP Kinases
  3. Anticancer, Antimicrobial, and Photocatalytic Activities of a New Pyrazole-Containing Thiosemicarbazone Ligand and Its Co(III) and Ni(II) Complexes
  4. Synthesis, Spectroscopy, and Structural Elucidation of Two New CoII and NiII Complexes of Pyrazole Derived Heterocyclic Schiff Base Ligand as Potential Anticancer and Photocatalytic Agents
  5. Vesicle-Encapsulated Rolipram (PDE4 Inhibitor) and Its Anticancer Activity
  6. Rhodamine Hydrazide-Linked Naphthalimide Derivative: Selective Naked Eye Detection of Cu2+, S2− and Understanding the Therapeutic Potential of the Copper Complex as an Anti-Cervical Cancer Agent
  7. Modulation and Determination of the Status of Inflammasomes in Leishmania-Infected Macrophages
  8. Catalytic and Anticancer Activity of Two New Ni(II) Complexes with a Pyrazole-Based Heterocyclic Schiff-Base Ligand
  9. Biophysical Study on DNA and BSA Binding Activity of Cu(II) Complex: Synthesis, Molecular Docking, Cytotoxic Activity, and Theoretical Approach
  10. Cytotoxic Behavior and DNA/BSA Binding Activity of Thiosemicarbazone-Based Ni(II) Complex: Bio-Physical, Molecular Docking, and DFT Study

Conclusion:

Dr. Arunima Biswas is an exceptional candidate for the “Best Researcher Award.” Her diverse research in cancer biology, parasitology, and drug development showcases her commitment to advancing healthcare. She has made significant strides in understanding complex molecular mechanisms, and her work holds great promise for improving cancer treatments. With a robust academic record, influential publications, and ongoing impactful projects, Dr. Biswas is undoubtedly a deserving contender for the award.

 

 

 

Felicia ANTOHE | Molecular Mechanisms Signaling | Molecular Cell Biology Award

Dr. Felicia ANTOHE | Molecular Mechanisms Signaling | Molecular Cell Biology Award

Dr. Felicia ANTOHE , Inst. Cellular Biology and Pathology NS , Romania

Dr. Felicia Antohe is the Head of the Proteomics Department at the Institute of Cellular Biology and Pathology, Romanian Academy. With a background in cellular biology and biophysics, she has contributed significantly to biomedical research, particularly in vascular endothelium, atherosclerosis, diabetes, and immune disorders. She has received multiple prestigious awards and conducted pioneering research, especially on the transcytosis of macromolecules in endothelial cells. As a PhD advisor, she mentors young researchers, having guided 12 PhD students to date. Dr. Antohe is an internationally recognized expert with extensive experience in immunology, cell biology, and proteomics.

Publication Profile:

Google Scholar

Strengths for the Award:

Dr. Felicia Antohe stands out as an exceptional candidate for the Research for Molecular Cell Biology Award due to her extensive academic and research achievements. As Head of the Proteomics Department at the Institute of Cellular Biology and Pathology, Romanian Academy, her leadership in pioneering research in endothelial cell biology and vascular pathologies has been transformative. Dr. Antohe’s strong academic background, with a Master’s in Biophysics and a PhD in Cellular Biology, complements her robust research portfolio. With over 170 scientific papers, 90 of which are indexed in Web of Science, she is recognized for her contributions to molecular mechanisms in diseases such as atherosclerosis, diabetes, and immune disorders. Furthermore, her work on monoclonal antibodies and proteomics has had a significant impact on both scientific and clinical advancements.

Areas for Improvement:

While Dr. Antohe’s research is highly regarded, there is potential for greater integration of her research with cutting-edge technologies in bioinformatics and computational biology. This could further expand her work on proteomics and molecular mechanisms. Additionally, there is an opportunity for broader outreach to apply her findings in practical therapeutic contexts through collaborations with pharmaceutical companies or clinical trials. Expanding her influence in translational research could have a larger impact on public health, especially in diseases such as diabetes and cardiovascular disorders.

Education:

Dr. Felicia Antohe holds a Master’s degree in Biophysics from the University of Bucharest (1977). She completed her PhD in Cellular Biology at the Romanian Academy’s Institute of Cellular Biology and Pathology (1994). In addition to her formal education, she has been a PhD coordinator since 2000 and has contributed significantly to research training at national and international levels. Her work blends theoretical knowledge with cutting-edge lab techniques in molecular biology, proteomics, and immunology.

Experience:

Dr. Antohe’s research experience spans numerous roles. She is currently the Principal Investigator and Member of the Scientific Council at the Romanian Academy’s Institute of Cellular Biology and Pathology. She has also worked as a visiting scientist at prestigious institutions like McGill University, University of Alberta, and Max Planck Institute. She has coordinated over 44 research projects, including national and international grants, and is actively involved in multiple collaborative research efforts across Europe and beyond. Her leadership in cell biology and proteomics is widely recognized.

Awards and Honors:

Dr. Antohe has received numerous awards, including the EURESCO Prize (2001), the BIO-RAD Laboratories Prize for valuable research (2002), and the Romanian Academy Emil Racovita Prize (1991). She has also won multiple international recognitions for her scientific contributions, such as the Best Poster award at the “8th International Conference on Vascular Endothelium” (2005), and various fellowships and grants from organizations like COST and the European Science Foundation.

Research Focus:

Dr. Antohe’s research focuses on endothelial cell biology, particularly transcytosis, endocytosis, and cell receptor mechanisms in both health and disease. She investigates the bio-pathology of atherosclerosis, diabetes, and immune disorders, with particular attention to the transport of macromolecules across vascular cells. Her work also explores the role of monoclonal antibodies as diagnostic and therapeutic tools. She applies proteomic techniques to study endothelial cell function, aiming to understand vascular biology at molecular and cellular levels.

Publications Top Notes:

  • The MHC class I-related receptor, FcRn, plays an essential role in the maternofetal transfer of γ-globulin in humans 📄
  • Functional expression of the MHC class I-related receptor, FcRn, in endothelial cells of mice 📄
  • Transcytosis of plasma macromolecules in endothelial cells: a cell biological survey 📄
  • Expression of functionally active FcRn and the differentiated bidirectional transport of IgG in human placental endothelial cells 📄
  • Analytical techniques for multiplex analysis of protein biomarkers 📄
  • Functional ultrastructure of the vascular endothelium: changes in various pathologies 📄
  • Effect of enoxaparin on high glucose-induced activation of endothelial cells 📄
  • Albumin-binding proteins function in the receptor-mediated binding and transcytosis of albumin across cultured endothelial cells 📄
  • Carbapenemase-Producing Klebsiella pneumoniae in Romania: A Six-Month Survey 📄
  • Establishment of a pure vascular endothelial cell line from human placenta 📄

Conclusion:

Dr. Felicia Antohe is an outstanding researcher whose work has greatly advanced our understanding of endothelial cell biology, molecular transport, and disease mechanisms. Her combination of technical expertise, leadership in multiple high-impact research projects, and numerous prestigious awards positions her as an ideal candidate for the Research for Molecular Cell Biology Award. While there is always room to expand her research applications, her contributions to science are already substantial and impactful.

 

 

 

Annoor Awadasseid | Cancer Cell Biology | Best Researcher Award

Dr. Annoor Awadasseid | Cancer Cell Biology | Best Researcher Award

Dr. Annoor Awadasseid , Zhejiang University of Technology , Sudan

Dr. Annoor Awadasseid is a dedicated biochemist and molecular biologist specializing in medicinal chemistry, with a profound focus on cancer treatment. With a rich background in the exploration of novel small-molecule compounds, his research is at the forefront of developing potential therapeutic drugs for oncology. Dr. Awadasseid has made significant contributions to biochemistry, molecular biology, and cancer therapy, integrating his expertise to evaluate promising compounds. Passionate about enhancing patient outcomes, he collaborates extensively with interdisciplinary teams and mentors junior researchers. Currently, he is a Senior Researcher at Hangzhou Qingzhenghong Technology Co., Ltd., where he leads oncology-focused R&D initiatives, developing novel cancer therapies. He has authored numerous high-impact publications, showcasing his commitment to advancing therapeutic approaches for cancer care.

Publication Profile:

Google Scholar

Strengths for the Award:

Dr. Annoor Awadasseid exhibits outstanding qualities as a researcher in the field of biochemistry and molecular biology, particularly within cancer therapeutics. His expertise in evaluating small-molecule compounds for cancer treatment is evident through his advanced knowledge of biochemical processes, medicinal chemistry, and molecular biology techniques. Dr. Awadasseid has significantly contributed to the design and development of novel therapeutic agents, particularly targeting the PD-1/PD-L1 immune checkpoint pathway, which is critical for cancer immunotherapy. His ability to collaborate with interdisciplinary teams and mentor junior researchers demonstrates a strong leadership role in advancing scientific knowledge and fostering innovation. His extensive publication record in prestigious journals, alongside the recognition he has received via multiple scholarships and awards, further attests to the high impact of his research and contributions to improving patient care.

Areas for Improvement:

While Dr. Awadasseid’s research is impressive and impactful, further diversification of research methodologies could enhance his work. For instance, incorporating more cutting-edge computational techniques and expanding collaborations with clinical research teams could accelerate the translation of his lab-based discoveries into clinical applications. Additionally, increasing visibility in international scientific conferences would allow Dr. Awadasseid to expand his professional network, share insights, and potentially collaborate on global-scale projects. Engaging in multidisciplinary research that spans beyond oncology could also create new avenues for discovery and broaden his research impact.

Education:

Dr. Awadasseid’s academic journey includes a Ph.D. in Medicinal Chemistry from the University of Chinese Academy of Sciences (2017-2020), where he specialized in the design and evaluation of therapeutic compounds. Prior to that, he earned another Ph.D. in Biochemistry and Molecular Biology from Dalian Medical University (2014-2017). His earlier studies culminated in a Master’s degree in Biochemistry and Molecular Biology from Northeast Normal University (2012-2014). These rigorous educational experiences have honed his skills in biochemical and molecular techniques, which form the foundation for his groundbreaking research in cancer therapy. Dr. Awadasseid’s extensive training across multiple renowned institutions equipped him with the tools to explore novel therapeutic pathways, ultimately paving the way for his contributions to drug discovery and cancer treatment.

Experience:

Dr. Awadasseid has over a decade of experience in biochemistry, molecular biology, and medicinal chemistry. Following his postdoctoral fellowship at Zhejiang University of Technology (2020-2024), where he focused on small-molecule drug evaluation for cancer therapy, he became a Senior Researcher at Hangzhou Qingzhenghong Technology Co., Ltd. (2024-present). In this role, he leads R&D initiatives, specializing in the discovery and development of novel small-molecule compounds for oncology. His work includes evaluating drug efficacy through preclinical models, optimizing therapeutic candidates, and integrating interdisciplinary insights to drive advancements in targeted cancer therapies. Dr. Awadasseid’s expertise spans a variety of techniques, including CRISPR/Cas9 gene editing, flow cytometry, and qPCR, supporting his pivotal contributions to improving cancer treatment and patient outcomes. He also mentors junior researchers and contributes to intellectual property creation, including patents and publications in prestigious journals.

Awards and Honors:

Dr. Awadasseid has received prestigious accolades throughout his career. He was awarded the CAS-TWAS President’s Fellowship Programme (2017-2020) for his Ph.D. studies at the University of Chinese Academy of Sciences, recognizing his potential for significant scientific contributions. Additionally, he received the Liaoning Provincial Government Scholarship (2014-2017) while pursuing his Ph.D. at Dalian Medical University. The Chinese Government Scholarship (2012-2014) was awarded to him for his Master’s degree studies at Northeast Normal University, reflecting his academic excellence and commitment to advancing research in biochemistry and molecular biology. These scholarships and awards highlight Dr. Awadasseid’s dedication to his field, his research accomplishments, and his potential to make lasting impacts in the realm of cancer therapy and medicinal chemistry.

Research Focus:

Dr. Awadasseid’s research is centered on the development and evaluation of novel small-molecule compounds for cancer treatment, specifically focusing on their mechanisms and potential as therapeutic agents. His work aims to identify promising candidates that could enhance patient outcomes in oncology. He has a strong interest in the design and synthesis of therapeutic molecules, particularly those targeting the PD-1/PD-L1 pathway and other key molecules involved in cancer progression. Through extensive preclinical testing, Dr. Awadasseid evaluates the efficacy of these compounds, with a particular emphasis on their ability to target specific cancer pathways, including apoptosis, immune response modulation, and signal transduction. His research employs a wide range of molecular and biochemical techniques, including CRISPR/Cas9 gene editing, qPCR, flow cytometry, and various microscopy methods, to assess the therapeutic potential of novel compounds. Ultimately, Dr. Awadasseid aims to contribute to the development of more effective, targeted therapies for cancer patients.

Publication Top Notes:

  1. Design, synthesis and biological evaluation of novel TMPRSS2-PROTACs with florosubstituted 4-guanidino-N-phenylbenzamide derivative ligands. 🔬💊
  2. Design, synthesis, and evaluation of antitumor activity of 2-arylmethoxy-4-(2-fluoromethyl-biphenyl-3-ylmethoxy) benzylamine derivatives as PD-1/PD-L1 inhibitors. 🧬💥
  3. Small molecule and PROTAC molecule experiments in vitro and in vivo, focusing on mouse PD-L1 and human PD-L1 differences as targets. 🔬🐭
  4. Recent advances and mechanisms of action of PD-L1 degraders as potential therapeutic agents. 💡📚
  5. Design, synthesis, anti-tumor activity and mechanism of novel PROTACs as degraders of PD-L1 and inhibitors of PD-1/PD-L1 interaction. 🔧🎯
  6. Current studies and future promises of PD-1 signal inhibitors in cervical cancer therapy. 🎗️🔬
  7. A Review on the Anticancer Activity of Carbazole-based Tricyclic Compounds. 📖🔍
  8. Design, Synthesis, and Antitumor Activity Evaluation of 2-Arylmethoxy-4-(2, 2′-dihalogen-substituted biphenyl-3-ylmethoxy) Benzylamine Derivatives as Potent PD-1/PD-L1 Inhibitors. 🧪🧫
  9. PD-L1 dimerisation induced by biphenyl derivatives mediates anti-breast cancer activity via the non-immune PD-L1–AKT–mTOR/Bcl2 pathway. 🧬💥
  10. Design, synthesis and bioactivity of novel naphthalimide-benzotriazole conjugates against A549 cells via targeting BCL2 G-quadruplex and inducing autophagy. 🧪⚡

Conclusion:

Dr. Awadasseid is undoubtedly a strong candidate for the Best Researcher Award due to his exceptional contributions to the field of cancer research. His innovative approach to discovering therapeutic small-molecule compounds, coupled with his ability to collaborate across disciplines, positions him as a leader in the biochemistry and molecular biology community. By continuing to refine his research techniques and expanding his collaborations, Dr. Awadasseid is likely to further enhance the scope and impact of his work. His ultimate goal of improving patient care and treatment modalities places him in alignment with the mission of the Best Researcher Award, making him a fitting candidate for this prestigious recognition.

 

 

 

ATM Yusuf | Phytochemistry | Best Researcher Award

Mr. ATM Yusuf | Phytochemistry | Best Researcher Award

Mr. ATM Yusuf  , University of Science and Technology Chittagong , Bangladesh

ATM Yusuf is an Assistant Professor in the Department of Pharmacy at the University of Science and Technology Chittagong (USTC), Bangladesh. He has extensive experience in teaching, research, and academia, with a focus on pharmacology and clinical pharmacy. Yusuf holds a Master of Pharmacy degree in Pharmacology and Clinical Pharmacy from North South University and a Bachelor of Pharmacy from the International Islamic University Chittagong. With a career spanning several academic institutions, he has contributed to a range of scientific studies and publications, particularly in the fields of medicinal plant pharmacology and pharmaceutical sciences. Yusuf is passionate about enhancing drug development through innovative research and has been an active participant in national and international academic communities.

Publication Profile:

Google Scholar

Strengths for the Award:

ATM Yusuf has demonstrated an outstanding commitment to advancing the field of pharmaceutical sciences. His research on medicinal plants, drug formulations, and pharmacology showcases his expertise and passion for improving health outcomes. He has a proven track record of publishing in prestigious journals, contributing significantly to the understanding of pharmacological properties of natural compounds, and has received substantial grants for his research. Furthermore, Yusuf’s teaching and mentoring in the Department of Pharmacy at USTC emphasize his dedication to both education and research. His interdisciplinary approach, combining in vivo and computational investigations, highlights his scientific versatility and the potential for groundbreaking discoveries in pharmaceutical sciences.

Areas for Improvement:

While Yusuf’s research contributions are notable, there is room for further expansion into clinical studies to complement his preclinical findings. In particular, increasing collaboration with clinical practitioners could provide practical applications for his pharmacological studies and broaden his research impact.

Education:

ATM Yusuf completed his Master of Pharmacy (M. Pharm) in Pharmacology and Clinical Pharmacy from North South University, Dhaka, in 2014. Prior to that, he earned his Bachelor of Pharmacy (B. Pharm) from the International Islamic University Chittagong in 2012. His foundational education in pharmacy was complemented by advanced studies in pharmacology, clinical pharmacy, and medicinal chemistry, which provided him with a strong academic grounding in drug development and therapeutic solutions. Yusuf also completed his Higher Secondary Certificate (H.S.C.) in 2007 from BN School and College in Chittagong and his Secondary School Certificate (S.S.C.) in 2005 from BEPZA Public School and College, Chittagong. His academic journey reflects a consistent commitment to pharmaceutical sciences, research, and education.

Experience:

ATM Yusuf has a broad academic background, currently serving as an Assistant Professor in the Department of Pharmacy at the University of Science and Technology Chittagong (USTC) since February 2022. Before this, he held the position of Lecturer at USTC (2018-2022) and at Ranada Prasad Shaha University (2017-2018). His experience spans both teaching and research, where he has taught a wide range of pharmacy-related subjects, contributing to the development of future pharmacists. In addition to his academic roles, he has served as the Assistant Proctor at USTC since December 2023, overseeing student affairs and academic integrity. Yusuf has also been involved in numerous research projects, focusing on medicinal plants, pharmacology, and drug formulation. His professional journey has been marked by a dedication to advancing pharmacy education, fostering student success, and producing high-impact research in pharmaceutical sciences.

Awards and Honors:

ATM Yusuf has earned recognition for his academic and research achievements. One notable honor is the 75% scholarship awarded to him throughout all semesters during his undergraduate studies at the International Islamic University Chittagong, reflecting his academic excellence. This scholarship highlights his commitment to academic achievement and sets a foundation for his future research endeavors. In addition to his scholarship, Yusuf has been awarded research grants, including the R&D Research Grant 2022-2023 from the Ministry of Science and Technology, Bangladesh, and the USTC Research Cell (URC) Grant in 2022. These grants support his continued research in pharmacology, medicinal plants, and drug development. His dedication to advancing knowledge in the field of pharmacy is evident in the recognition he has received from both educational institutions and research organizations.

Research Focus:

ATM Yusuf’s research primarily revolves around pharmacology, medicinal plants, and the development of novel drug formulations. He has focused on investigating the phytochemistry and pharmacology of various plant species, exploring their potential therapeutic applications. Yusuf’s studies on Delonix regia, Ganoderma lucidum, and Citrus maxima exemplify his commitment to studying the medicinal properties of plants and their roles in treating diseases. His research also spans computational and in vivo investigations, aimed at understanding the biochemical and pharmacological effects of natural compounds. Additionally, Yusuf has explored drug formulation strategies, such as solid dispersions to enhance the dissolution rate of poorly soluble drugs like Ketoprofen. Through his research, he aims to bridge the gap between traditional medicine and modern pharmacological practices, contributing valuable knowledge to the field of pharmaceutical sciences and drug development.

Publication Top Notes:

  1. In-Vitro Cytotoxic and Thrombolytic Potential of Pothos scandens L. 💊🌿
  2. In vitro Anti-arthritic and Thrombolytic activities of Protium serratum L. 💪💉
  3. Evaluation of cytotoxic and thrombolytic activities of Sida acuta. 🧬💥
  4. Glucosidase Inhibitory Effects of Unani, Ayurvedic, and Homeopathic medicines. 🌱💊
  5. Non-clinical evaluation of antioxidant and anti-inflammatory activity of Citrus maxima peel extract. 🍊💪
  6. Protective and toxicogenetic aspects of Piper betle. 🍃🔬
  7. Improvement of Dissolution Rate of Ketoprofen Using Solid Dispersions. 💊🔬
  8. Phytochemical and the Antibacterial, Antifungal, and Cytotoxic Activities of Alstonia scholaris. 🍃💉
  9. Investigation of Ceftibuten with Antacid and Metal Interaction. 💊⚖️
  10. Profiling of phytochemicals and antioxidant activity of wild mushrooms. 🍄🧪

Conclusion:

ATM Yusuf is a promising candidate for the Research for Best Researcher Award. His academic achievements, research output, and dedication to advancing pharmaceutical sciences make him a highly suitable choice. With ongoing growth in clinical research, Yusuf has the potential to make even greater contributions to the field. His work continues to inspire both students and colleagues alike, and his leadership in research will likely yield even more impactful results in the future.

 

 

 

Ayrton Bangolo | Cancer Cell Biology | Best Researcher Award

Dr. Ayrton Bangolo | Cancer Cell Biology | Best Researcher Award

Dr. Ayrton Bangolo , Hackensack University Medical Center , United States

Ayrton I. Bangolo, MD, is an accomplished board-certified Internal Medicine physician specializing in Hematology and Oncology. He completed his MBBS (equivalent to MD) from Tianjin Medical University, China, in 2016 and is currently a Hematology and Oncology fellow at Hackensack University Medical Center, NJ. With an impressive record of research publications and contributions to several medical journals, he has a passion for advancing cancer care and the clinical aspects of various diseases. Dr. Bangolo is deeply involved in both clinical practice and research, having worked in multiple specialties and international medical settings. His expertise is enriched by his diverse experiences across different clinical environments, from hospitals in the United States to clinics in the Democratic Republic of the Congo. He holds a variety of leadership roles, demonstrating commitment to the global advancement of healthcare.

Publication Profile:

Google Scholar

Strengths for the Award:

Dr. Ayrton I. Bangolo’s exceptional contributions to the medical field make him a strong candidate for the “Best Researcher Award.” His work spans critical areas of oncology, including the impact of tumor stage and histopathology on survival outcomes in esophageal cancer, as well as his pioneering research on the gut microbiome’s role in pancreatic cancer treatment. His academic rigor is evident through his prolific research output and successful collaboration with international researchers. Additionally, Dr. Bangolo’s role as a peer reviewer for prominent medical journals underscores his expertise and respect in the medical community. His focus on racial, ethnic, and socioeconomic disparities in cancer care reflects his commitment to improving healthcare outcomes for underserved populations. Moreover, his ongoing research aims to bridge knowledge gaps in critical areas such as thyroid cancer management and gastrointestinal malignancies.

Areas for Improvement:

While Dr. Bangolo’s work is impressive, expanding his collaborative efforts to include more interdisciplinary research could enhance his scope even further. Although his focus on cancer disparities is commendable, there may be opportunities to expand his research into other areas of healthcare equity, such as mental health in cancer patients or global access to cancer treatments. Additionally, increasing involvement in clinical trials may provide real-world validation for his findings, leading to more practical applications in patient care.

Education:

Dr. Bangolo obtained his MBBS from Tianjin Medical University, Tianjin, China, in 2016, and has earned multiple certifications in the United States, including the ECFMG certification. He has successfully completed the USMLE exams, passing all steps (1, 2, and 3) on the first attempt. Dr. Bangolo is currently undergoing advanced training in Hematology and Oncology at Hackensack University Medical Center, NJ, in an ACGME-accredited fellowship program. His prior residency in Internal Medicine and a transitional year at Palisades Medical Center, North Bergen, NJ, has further honed his skills. Throughout his education, Dr. Bangolo has consistently demonstrated academic excellence and a commitment to evidence-based practice. His journey through diverse healthcare systems and international medical education reflects his dedication to global health improvement and patient-centered care.

Experience:

Dr. Bangolo has extensive clinical experience spanning multiple specialties, beginning with his externship and observership roles in Endocrinology, Nephrology, and Interventional Radiology. He served at Endocrine Associates in Louisville, KY, and worked with Dr. Hisham Alrefai in Endocrinology and Dr. Mohammed El Kheir in Nephrology. His residency in Internal Medicine at Palisades Medical Center, North Bergen, NJ, allowed him to build foundational skills in patient care and management across various medical conditions. Currently, he is completing an ACGME-accredited fellowship in Hematology and Oncology at Hackensack University Medical Center, where he continues to refine his expertise in treating complex cancer patients. Additionally, Dr. Bangolo has contributed to clinical research and presented at various academic conferences. His exposure to diverse medical environments, from the US to the Democratic Republic of the Congo, gives him a well-rounded perspective on healthcare delivery.

Awards and Honors:

Dr. Bangolo has received numerous awards and accolades, highlighting his outstanding contributions to the medical field. Among his notable recognitions is the 2nd Place for his original research poster on “Racial/Ethnic and Socioeconomic Differences in Colon Cancer Surgery Performed” during the HMH North Region Fellow/Residents Research Day. He was also involved in publishing open-access articles on significant public health issues, including the United Nations Sustainable Development Goals related to cancer treatment disparities. Dr. Bangolo’s work on ultrasound performance in the diagnosis of thyroid cancer earned recognition in the scientific community. His publications have made significant impacts, including in journals such as Breast Cancer Research and Treatment and World Journal of Gastroenterology. His consistent dedication to advancing medical knowledge, addressing healthcare disparities, and improving treatment outcomes has made him a respected figure in his field.

Research Focus:

Dr. Bangolo’s research primarily focuses on oncology, with a particular emphasis on cancer disparities, treatment outcomes, and innovative diagnostic methods. He has extensively studied the impacts of tumor stage and histopathology on survival outcomes in esophageal cancer and the influence of primary percutaneous coronary intervention on myocardial infarction outcomes. His work also includes investigating trends in thyroid cancer incidence, improving the understanding of gastrointestinal cancers, and exploring the role of the microbiome in pancreatic cancer. Dr. Bangolo is dedicated to researching the epidemiological factors that influence cancer outcomes in underserved populations, with a particular interest in racial, ethnic, and socioeconomic differences in treatment and survival. His ongoing research aims to improve treatment protocols and contribute to global cancer care, especially in resource-limited settings like the Democratic Republic of the Congo, where he has firsthand experience working.

Publications Top Notes:

  1. The Impact of Tumor Stage and Histopathology on Survival Outcomes in Esophageal Cancer Patients 📑
  2. Comprehensive Analysis of the Impact of Primary Percutaneous Coronary Intervention on Patients with ST-Segment Elevation Myocardial Infarction 💓
  3. Impact of American Thyroid Association’s Revised Cancer Management Guidelines on Thyroid Cancer Incidence Trends 📊
  4. Racial/Ethnic and Socioeconomic Differences in Colon Cancer Surgery Performed and Delayed Surgical Treatment 🎗️
  5. Ultrasound Performance Using the EU-TIRADS Score in the Diagnosis of Thyroid Cancer 🩺
  6. Epidemiologic Risk Factors for Chronic Pancreatitis and Pancreatic Ductal Adenocarcinoma 🦠
  7. Impact of Gut Microbiome in the Development and Treatment of Pancreatic Cancer 🧬
  8. Primary Cardiac Sarcoma: Clinical Characteristics and Prognostic Factors ❤️
  9. The Overall Quality of Evidence of Recommendations Surrounding Nutrition and Diet in Inflammatory Bowel Disease 🥗
  10. Outcomes of Patients with Gastrointestinal Stromal Tumors in the Past Decade 💉

Conclusion:

Dr. Ayrton I. Bangolo is undoubtedly a leading researcher in the field of oncology, with a robust academic and clinical background, significant contributions to medical literature, and a passion for addressing global healthcare disparities. His dedication to understanding complex diseases, combined with his focus on improving patient outcomes, positions him as a deserving candidate for the “Best Researcher Award.” Expanding his research to incorporate broader interdisciplinary efforts and clinical trials would further elevate his impact.

 

 

 

Salam Bani Hani | Cell Structure Analysis | Best Researcher Award

Dr. Salam Bani Hani | Cell Structure Analysis | Best Researcher Award

Dr. Salam Bani Hani , Irbid National University , Jordan

Dr. Salam Bani Hani is an Assistant Professor and Head of the Nursing Department at Irbid National University, Jordan. She holds a PhD in Nursing Philosophy from the University of Jordan, where she earned a perfect GPA of 4/4. She also holds an MSc in Nursing Service Administration from Jordan University of Science and Technology and a BSN from Al-Al Bayt University. Dr. Bani Hani has a strong academic background, and her research primarily focuses on nursing documentation, healthcare data, and predictive models in healthcare. In addition to her academic role, she has extensive clinical experience, having worked as a patient and family educator in Qatar and a clinical instructor at Al-Al Bayt University. She has made significant contributions to nursing education and research, publishing numerous studies in international journals and presenting at conferences globally. Her expertise bridges clinical practice and academic advancement.

Publication Profile:

Google Scholar

Strengths for the Award:

Dr. Salam Bani Hani demonstrates remarkable expertise in nursing research, with a clear focus on the integration of technology and data analytics in healthcare. Her work on using large-scale data to predict ischemic heart disease and her contributions to nursing documentation through comparative studies of paper-based and electronic health records reflect her ability to tackle relevant, contemporary issues in healthcare. Her research has been widely published in respected journals, with numerous articles on topics such as digital health literacy, the use of artificial intelligence in healthcare, and predicting mortality in heart disease patients. Her academic excellence, reflected in her perfect PhD GPA, coupled with her extensive teaching experience, makes her an exemplary candidate for this award.

Areas for Improvement:

While Dr. Bani Hani’s academic and clinical achievements are impressive, further engagement in collaborative, interdisciplinary research could enhance the impact of her work. Additionally, expanding her outreach through international conferences and workshops could elevate her profile even further.

Education:

Dr. Salam Bani Hani holds a PhD in Nursing Philosophy from the University of Jordan (2019–2022), graduating with an exceptional GPA of 4/4. Her dissertation focused on predicting ischemic heart disease in the Jordanian population using large-scale data. She also holds a Master of Science in Nursing (MSc) in Nursing Service Administration from Jordan University of Science and Technology, where she received a GPA of 94.1. Her thesis explored the quality of nursing documentation, comparing paper-based and electronic health records. She completed her Bachelor of Science in Nursing (BSN) at Al-Al Bayt University in 2011 with an excellent GPA of 88.7. Dr. Bani Hani’s academic achievements are complemented by various specialized training courses, including life support, pain management, and simulation education, all of which contribute to her comprehensive expertise in nursing and healthcare.

Experience:

Dr. Salam Bani Hani currently serves as an Assistant Professor and Head of the Nursing Department at Irbid National University, Jordan. She has been in this role since November 2023. Previously, she was a Clinical Instructor at Al-Al Bayt University, teaching across various nursing fields such as medical-surgical, emergency, and critical care. She has also served as a Patient and Family Educator at Hamad Medical City, Qatar, from 2018 to 2019. Dr. Bani Hani started her clinical career as a Staff Nurse in the emergency ward at Jordan University Hospital, one of the leading hospitals in the Middle East. She has extensive experience in both clinical practice and teaching, specializing in nursing education, patient care, and healthcare management. Additionally, she actively participates in various professional development programs and workshops, contributing significantly to both academia and practice in the nursing field.

Awards and Honors:

Dr. Salam Bani Hani has received numerous accolades in recognition of her academic and professional achievements. She earned the highest honors in her PhD studies, graduating with a perfect GPA of 4/4 from the University of Jordan. Throughout her career, she has contributed to advancing nursing education and practice, and her work has been published in several prestigious journals. Additionally, she has been involved in organizing and attending key nursing conferences, including the 2nd International Nursing Conference in 2023. Dr. Bani Hani’s work in the realm of healthcare data analysis, digital health, and nursing documentation has earned her recognition in both academic and clinical settings. Her dedication to improving healthcare delivery through research and education has been recognized by peers and institutions, positioning her as a leader in the nursing profession. She has also contributed significantly to nursing education through various workshops and specialized training programs.

Research Focus:

Dr. Salam Bani Hani’s research focuses on the intersection of nursing education, digital health, and predictive healthcare models. Her PhD dissertation explored the use of large-scale data to predict ischemic heart disease among the Jordanian population, which aligns with her research interest in healthcare data analytics. She has extensively researched nursing documentation, comparing paper-based versus electronic health records, and has contributed to advancing the field of digital health literacy. Dr. Bani Hani is particularly interested in the application of artificial intelligence (AI) and machine learning in healthcare, with research that investigates how AI can be used to improve patient care and support healthcare decision-making. Her work also delves into the competencies required for oncology nurses and the role of technology in improving clinical practices. Additionally, she has explored the impact of COVID-19 on nursing practices and is actively involved in enhancing nursing education through blended learning and interactive training.

Publications Top Notes:

  • Quality of nursing documentation: Paper‐based health records versus electronic‐based health records 📚
  • Machine-learning algorithms for ischemic heart disease prediction: a systematic review 💻
  • Attitudes of Jordanian Oncology Nurses Toward Computerization 📊
  • Electronic health literacy and its association with lifestyle behavior among undergraduate students 💡
  • Assessment of genetic variation among Jordanian barley landraces (Hordeum vulgare L.) 🌾
  • Large-scale data in health care: a concept analysis 🏥
  • Transforming cancer clinical trials: The integral role of artificial intelligence in electronic health records 🤖
  • Effective prediction of mortality by heart disease among women in Jordan using the chi-squared automatic interaction detection model 🩺
  • Effectiveness of blended learning basic life support module on knowledge and skills: A systematic review of randomized controlled trials 💡
  • Assessing digital health literacy level among nurses in Jordanian hospitals 🏥

Conclusion:

Dr. Salam Bani Hani is highly deserving of the Research for Best Researcher Award. Her consistent contributions to advancing nursing practice, her innovative use of technology in healthcare, and her rigorous academic achievements reflect her commitment to improving patient care and nursing education. With her comprehensive skill set and dedication, she continues to make significant strides in both clinical and academic research, positioning her as a leader in her field.

 

 

 

Ndèye Aby NDOYE | Cell Differentiation Processes | Women Researcher Award

Prof. Ndèye Aby NDOYE | Cell Differentiation Processes | Women Researcher Award

Prof. Ndèye Aby NDOYE , Faculty of Medicine, Cheikh Anta Diop University, Senegal , Senegal

Prof. .Ndèye Aby NDOYE is a dedicated pediatric surgeon from Senegal, specializing in disorders of sexual development (DSDs) and pediatric surgical interventions. With a deep commitment to improving child health, she has contributed significantly to research in pediatric surgery, focusing on the diagnosis and treatment of rare conditions. Her work aims to enhance surgical outcomes and patient care in the African context. prof. Ndèye Aby NDOYE has presented at numerous medical conferences, collaborated with international experts, and worked extensively within Senegal’s leading medical institutions. Passionate about advancing pediatric healthcare, she is driven by the goal of making specialized medical services more accessible to children in sub-Saharan Africa.

Publication Profile:

Scopus

Strengths for the Award:

  1. Strong Research Output: The individual has contributed significantly to the research in pediatric surgery, specifically in disorders of sexual development (DSDs) and related conditions, showing a diverse range of publications. Their work is essential for advancing medical knowledge in these rare and complex conditions.
  2. Focus on Underrepresented Issues: The research primarily focuses on pediatric DSDs and congenital conditions in sub-Saharan Africa, which is an underrepresented and crucial area of study. By addressing these unique healthcare challenges, the researcher is contributing to medical knowledge that can significantly impact pediatric surgery outcomes in low-resource settings.
  3. Multidisciplinary Approach: The research covers a wide spectrum of topics, from the diagnostic aspects of congenital malformations to the management of complex surgeries, which showcases the individual’s broad expertise in pediatric healthcare.
  4. Commitment to Healthcare in Africa: Working in Senegal and contributing to the improvement of pediatric care in the region, the researcher is addressing both medical and infrastructural challenges in sub-Saharan Africa, an area where access to specialized care is limited. Their work is instrumental in enhancing local healthcare practices.
  5. Patient-Centered Approach: The research takes into account both the clinical and psychological impacts of these conditions, focusing on gender reassignment, the surgical outcomes, and post-operative recovery, particularly in the context of pediatric patients.

Areas for Improvement:

  1. Collaboration & Visibility: While the researcher has contributed to multiple articles, further collaboration with international researchers or institutions could potentially elevate the visibility and impact of their work. Engaging in more global research networks might allow for better knowledge dissemination.
  2. Long-Term Impact Measurement: The research could benefit from more longitudinal studies that follow up on patients long-term to track the evolution of outcomes after surgeries like gonadectomy and genitoplasty. This could provide more comprehensive insights into the long-term implications of the surgeries and improve patient care further.
  3. Expanding Research Focus: Although the researcher has made substantial contributions to understanding pediatric DSDs, expanding the research to explore other related areas such as genetic research or advanced surgical techniques might provide a more holistic approach to treating pediatric conditions.

Education (150 words):

Prof. Ndèye Aby NDOYE obtained her medical degree from the University of Faculty of Medicine, Cheikh Anta Diop University, Senegal, followed by specialized training in pediatric surgery at Faculty of Medicine, Cheikh Anta Diop University, Senegal. She pursued further fellowship studies in pediatric surgical subspecialties, focusing on complex congenital anomalies. Prof. Ndèye Aby NDOYE also completed advanced studies in the diagnosis and management of disorders of sexual development (DSDs), receiving mentorship from renowned pediatric surgeons internationally. She is committed to continuous learning, having attended several international workshops and seminars on pediatric surgery, genetics, and child health. Her academic journey has been marked by a passion for clinical excellence and a drive to bring innovative solutions to pediatric care in Africa.

Experience (150 words):

Prof. Ndèye Aby NDOYE has extensive clinical experience in pediatric surgery, having worked at the Albert Royer National Children’s Hospital Center in Dakar, one of the leading institutions in Senegal. She has managed a variety of complex cases, including ovotesticular DSDs, congenital diaphragmatic hernia, and gastrointestinal malformations. Her clinical expertise spans diagnostics, surgical interventions, and post-operative care for children with rare and complex medical conditions. Prof. Ndèye Aby NDOYE has been instrumental in improving clinical protocols and patient management within the department. Her collaborative approach with local and international teams has led to several research initiatives aimed at improving pediatric surgical outcomes in Africa. Her work has contributed to advancing knowledge on pediatric conditions, while also advocating for better medical infrastructure and resources to support children’s healthcare in sub-Saharan Africa.

Research Focus (150 words):

Prof. Ndèye Aby NDOYE research primarily focuses on disorders of sexual development (DSDs) in pediatric patients, aiming to improve diagnostic methods, treatment approaches, and long-term outcomes. She is particularly interested in ovotesticular DSDs and gender reassignment in pediatric surgery. Her work includes investigating genetic, hormonal, and surgical aspects of these conditions, while considering cultural, ethical, and regional challenges. Prof. Ndèye Aby NDOYE also studies the epidemiology and management of pediatric congenital anomalies in sub-Saharan Africa, emphasizing the need for accurate diagnosis and timely surgical intervention. Additionally, her research explores pediatric surgical outcomes, with an interest in identifying risk factors and improving post-operative care for children undergoing complex surgeries. By focusing on improving access to quality healthcare in Africa, Prof. Ndèye Aby NDOYE seeks to bring more attention to the unique medical needs of children in low-resource settings.

Publications (Titles with Emojis):

  1. “Ileal Perforation Peritonitis Secondary to Ingestion of Magnetic Beads in the Older Child: A Case Report” 🧠🍽️
  2. “Intravaginal Foreign Body: A Rare Cause of Persistent Vaginal Discharge in a Child” 🩺🚼
  3. “Telomere Dysfunction in Pediatric Patients with Differences/Disorders of Sexual Development” 🔬🧬
  4. “Factors Associated with Mortality in Congenital Malformations of the Gastrointestinal Tract in a Tertiary Center in Senegal” 💀🩻
  5. “Pediatric Umbilical Hernia: Is Repair with Continuous Suture Safe?” 🤔🔩
  6. “Conservative Management of Urethral Prolapse in African Girls: A Report of 15 Cases” 💡🩺
  7. “Management of Congenital Diaphragmatic Hernia in Sub-Saharan Africa: Experience in the Albert Royer National Children’s Hospital Center, Senegal” 🌍👶
  8. “Choledochal Cyst in Children in Dakar: Diagnostic and Therapeutic Aspects” 🏥🔍
  9. “Meckel’s Diverticulitis by Ascaris in Children: About a Case” 🐛🩺
  10. “Omphalomesenteric Fistulas: Epidemiological Diagnostic and Therapeutic Features” ⚠️👶

Conclusion:

The individual is highly suitable for the Research for Women Researcher Award due to their impactful contributions to pediatric surgery research, particularly in the challenging context of sub-Saharan Africa. Their work addresses critical health issues related to sexual development disorders and congenital conditions, significantly enhancing medical care and understanding in an underrepresented field. With some improvements in global collaboration and expanding their research focus, they can further solidify their impact on global pediatric health.

 

 

 

Paola Cynthia Demeni Emoh | Endophytic fungi | Young Scientist Award

Mrs. Paola Cynthia Demeni Emoh | Endophytic fungi | Young Scientist Award

Mrs. Paola Cynthia Demeni Emoh , University of Yaoundé 1 , Cameroon

Cynthia Paola Demeni Emoh is a Ph.D. candidate in Medical Microbiology at the University of Yaoundé I, Cameroon. She has a keen interest in the antimicrobial properties of natural products and their potential applications in treating infectious diseases like malaria and pneumonia. Cynthia also serves as a part-time lecturer, teaching microbiology practicals at her university. She is an active researcher and has contributed to multiple systematic reviews and meta-analyses, focusing on infectious diseases. Her collaborations with international networks, such as the AGNES and YaBiNaPA programs, have expanded her research reach. Cynthia is also a member of the American Society of Microbiology and a contributor to various scientific journals. With her solid academic background and dedication to scientific advancement, Cynthia continues to strive for excellence in both her research and teaching roles.

Publication Profile:

Orcid

Strengths for the Award:

Cynthia Paola Demeni Emoh is an outstanding candidate for the Research for Young Scientist Award due to her extensive academic background, innovative research, and significant contributions to microbiology. Her work on endophytic fungi and infectious diseases, particularly malaria, demonstrates her commitment to addressing public health challenges in sub-Saharan Africa. Her experience with systematic reviews and meta-analyses further highlights her expertise in synthesizing global data to drive scientific advancements.

Areas for Improvement:

While Cynthia has established a strong foundation in microbiology, she could benefit from additional experience in interdisciplinary research, particularly in translational science. Collaborations with clinicians or public health experts could broaden her research’s practical applications and improve its potential for real-world impact.

Education:

Cynthia’s educational journey began at the University of Yaoundé I, where she earned her Bachelor’s degree in Microbiology in 2016. She later pursued a Master’s degree in Medical Microbiology at the same institution, which she completed in 2019. During her master’s program, she focused on assessing the antibacterial properties of endophytic fungi isolated from Alstonia boonei and Greenwayodendron suaveolens, particularly their effectiveness against pneumonia bacteria. Building on her master’s research, Cynthia is now a Ph.D. candidate in Medical Microbiology at the University of Yaoundé I. Her Ph.D. research, initiated in 2020, examines the antiplasmodial activity of endophytic fungi extracts from Alstonia boonei and their modes of action. Cynthia’s academic trajectory is shaped by a solid foundation in microbiology, driven by her interest in infectious diseases and their treatment. She has also earned a Baccalaureate in Life Sciences from François Xavier Vogt College in Yaoundé.

Experience:

Cynthia’s professional experience spans both teaching and research in microbiology. She has been a part-time lecturer at the University of Yaoundé I since October 2018, where she is responsible for the practical component of microbiology courses. She has also contributed significantly as an assistant researcher at the Biotechnology Centre of the University of Yaoundé I in 2019, where she worked on phytopathology. Cynthia’s research experience extends beyond Cameroon, having completed an internship at the University of Abomey-Calavi in Benin in 2023, focusing on applied microbiology and pharmacology. Additionally, she interned at the Centre Pasteur of Cameroon in 2022 and 2023, contributing to malaria research. She has been a member of various research groups, including the Systematic Reviews and Meta-Analysis team led by Dr. Kenmoe Sebastien at the Centre Pasteur of Cameroon. Cynthia’s research output and collaborations have strengthened her expertise in microbiology, especially in the areas of infectious diseases and natural products.

Research Focus:

Cynthia’s research focuses on investigating the antimicrobial properties of endophytic fungi extracts, with particular emphasis on their antiplasmodial and antibacterial activities. Her Ph.D. research centers on the antiplasmodial effects of fungi isolated from Alstonia boonei, a plant known for its medicinal properties. She explores how these fungal extracts can serve as alternative treatments for malaria by assessing their activity against Plasmodium falciparum. Cynthia’s earlier work, during her Master’s program, also centered on the antibacterial properties of endophytic fungi from Alstonia boonei and Greenwayodendron suaveolens and their ability to combat pneumonia bacteria. In addition to her laboratory studies, she has contributed to systematic reviews and meta-analyses, analyzing the prevalence, risk factors, and epidemiology of various infectious diseases, such as hepatitis, tuberculosis, and Crimean-Congo hemorrhagic fever. Cynthia’s research is driven by the need for novel antimicrobial agents, especially against drug-resistant pathogens and emerging diseases in sub-Saharan Africa.

Publication Top Notes:

  1. Assessment of the antiplasmodial and cytotoxicity effects of ethyl acetate extracts against Plasmodium falciparum strains (2025) 🦠🧪
  2. Morphological and molecular characterization of endophytic fungi isolated from Alstonia boonei De Wild (2025) 🔬🍄
  3. Stage-Dependent Release of Plasmodium Falciparum Homolog of T-Cell Immunomodulatory Protein and Suppression of Macrophage-Inflammatory Protein-1 (2025) 🦠💉
  4. Isolation, identification of endophytic fungi from Codiaeum variegatum and assessment of anti-amoebic and anti-inflammatory potential (2024) 🍄🌱
  5. Systematic review with meta-analysis of the global host range of Mycobacterium ulcerans (2024) 🌍🦠
  6. Hepatitis B, C, and D virus infections and risk of hepatocellular carcinoma in Africa (2022) 🦠🌍
  7. Global prevalence and case fatality rate of Enterovirus D68 infections (2022) 🌍🦠
  8. Systematic review of Crimean-Congo Hemorrhagic Fever Virus epidemiology in humans and animals (2021) 🩸🦠
  9. Worldwide epidemiology of Lassa virus in humans and rodents (2020) 🌍🦠
  10. Influence of confounding factors on associations between viral LRTI and subsequent wheezing development (2021) 🧳👶

Conclusion:

Cynthia is a promising young researcher with a clear focus on addressing critical health issues. Her dedication to advancing scientific knowledge, particularly in the fight against infectious diseases, makes her an excellent candidate for the Research for Young Scientist Award.